The high responder group showed 3 separate patterns: 1) reduction free system. The only nucleotide sequence abnormality occurs of inhibitor & prevention of anamnestic response as long ascyclowithin the sinall intervening sequence (intron) and creates a phosphamide therapy was maintained; 2) disappearance of inhibipotential anomalous splicing site in the mRNA precursor, suggestor & no recurrence when exposed to Factor VIII after cyclophosting a structural basis for defective processing. In four addiphamide therapy termination; 3) persistence of inhibitor but in tional patients, defective 0 mRNA processing was also observed.
low responder range without anamnestic response to Factor VIII The initial 6/a 3~ mRNA ratios of pulse-labeled RNA were normal, infusions after cyclophosphamide therapy termination. Controls indicating normal transcription, but abnormally high accumuladeveloped an anamnestic inhibitor response each time they were ti0n of unprocessed @ mRNA precursur sequences (introns) occurrexposed to Factor VIII. The low responder group showed2patterns: ed in each case. A fifth patient exhibited normal 3~ @ mRNA 1) disappearance of inhibitor without recurrence when exposed to synthesis and processing in nuclear RNA, but @ mRNA in cytoFactor VIII; 2) persistence of inhibitor in low responder range. plasm declined to steady-state levels during a 20-hour "chase,"
The low responders reacted the same during immunosuppression & indicating cytoplasmic instability. These studies identify at after termination of the immunosuppression therapy. Controls least two distinct post-transcriptional lesions in @ mRNA metabshowed the same results as the protocol group. It is evidentfrom 0lism in 6-thal: inefficient processing of introns and cytothese results that immunosuppression was apparently unnecessary plasmic instability of mature @ mRNA.
for the low responders but gave beneficial results with the high responders. TO establ ish whether degranul ation is an important prerequihave evaluated the relationship of white cell count to the pressite for granulocyte (PMN) aggregation, we employed the chemoence of hemolysis using carboxyhemoglobin as an index of red cell attractant synthetic peptides Gly-His-Gly (GHG) and n-formyl-Metdestruction.
CARBOXYHEMOGLOBIN VALUES IN INFANTS WITH ELEVATED
Leu-Phe (FMLP). As previously shown, GHG caused chemotaxis of Twenty-eight infants, 2-28 days of age, with elevated total PMN at 10 ug/ml. GHG at concentrations of 10, 15, and 50 uglml PMN counts (as defined by the Manroe reference range, J , of Ped.
did not cause degranulation of cytochalasin (CB)-treated PMN g5:8g '79) had carboxyhemoglobin (H~co%) determinations performed.
beyond that observed for control as measured by the percent total All infants were screened for other causes of increased total PMN release of the granular constituent lysozyme into supernate (GHG counts and none were septic or had a previously diagnosed hemo-8.4%; control 8.7%). GHG also did not cause release of the cytol ytic process.
plasmic constituent LDH (GHG 5.9% of total; control 4.0%). GHG Fourteen (50%) of these infants had evidence of hemolysis with (range 12.5 to 100 uglml) also did not induce aggregation of CBan elevated HbCo%(>0.9%). The mean total PMN count in the group treat d PMN as measured by light scattering. In contrast, with hemolysis was 14,670+7,000 and in the group without hemo2x10-9 M FMLP provoked the release of lysozyme (33% of total) from lysis it was 8,900?4,600. All infants with total PMN counts granules, but not release of LDH (5.3% of total), and caused greater than 15,000 had elevated HbCo% values. Repeat HbCo% aggregation of CB-treated PMN. When CB-treated PMN were incudeterminations were done in the hemolytic group when the total bated with GHG (15 uglml) followed by FIILP, there was no inhi-PMN counts returned to normal. All repeat HbCo% values were withbition of lysozyme release (29.2% of total) nor of PMN aggregain the normal range.
tion. These studies suggest thgt GHG and FMLP interact with the Increased total PMN counts can be used to identify some PMN at distinct loci. Although GHG is chemotactic for PMN it infants with previously undiagnosed hemolytic disease. Infants failes to induce PMN aggregation, probably through its inability wit,h jaundice and elevated white cell count should be suspected to provoke degranul ation. of having an associated hemolytic anemia particularly when the total PMN count is greater than 15,000/mm3. Following exposure of granulocytes (PMN) to chemotactic fatof two types: idiopathic and dose-related. In the dose-related tors in vitro, the cells will degranulate and aggregate and Upon toxicity, recent reviews emphasized the red cell changes and comi n f u s~n~h e m o t a c t i c factors in vivo animals will be rendered mented that neutropenia is rare. In order to assess clinically neutropenic. In order to a s s e s s w h m r the specific granule significant marrow toxicity, we reviewed charts of 56 patients product lactoferrin (LF) could mediate PMN stickiness in vitro treated with chloramphenicol between August 1975 and August 1980. and in vivo, PMN were exposed to human LF in vitro a n d n m These patients were treated for life-threatening infections, were infused with LF in vivo. LF at c o n c e n t r a s as low as 6 either meningitis or epiglotitis, believed to be caused by uglml aggregated humanPMNnd 12 ug/ml LF promoted their attachHemophilus influenzae. All patients were treated with chloramment to human umbilical endothel ial (44 + 4% control compared to phenicol at a dose of 100 mglkgld. There were 17 patients with 55 + 4% LF-treated). Infusion of 1 mg/k< LF into rabbits caused epiglotitis, the mean age being 45 months (range 12-96 mos.) 1 a 4F% fall in PMN count by 2 min; whereas 2 mqlkg of transferrin One patient in this group developed neutropenia (ANCt1500/mm ) .
THE INCIDENCE OF CHLORAMPHENICOL-INDUCED
or granule lysozyme lacked any effect. In order to visually Thirty-nine patients had meningitis, the mean age being 18.9 assess the effect of LF, the hampster cheek pouch was prepared months (range 4-84 mos.).
Of the 39, eight developed neutrofor in vivo microcirculation observation by displaying a venule penis. Of patients treated with chloramphenicol, 14 were less on aTV-monitor. The number of PMN passing a segment of the than 12 months of age and 42 were older than 12 months of age.
venule was then determined. Within 20-30 seconds after adminisThe mean onset of neutropenia was 9 days into therapy. The tration of 70 to 280 ug rabbit LF1100g to hampsters the PMN rollincidence of neutropenia was 2/42 for those patients greater ing frequency markedly decreased. PMN stickiness was then SUSthan one year old and 7/14 for those less than one year of age.
tained for 3-5 min. In contrast intravenous administration of We believe our data indicates that neutropenia is a clinically a1 bumin or transferrin lacked effect. These studies indicate significant side effect, particularly in patients less than 12 that the PMN LF can sustain PMN autostickiness and serve to medmonths of age. Such findings emphasize the need to measure iate the effect of chemotactic factor in rendering animals chloramphenicol levels in the child less than one year old.
neutropenic.
